Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Law, history and lessons in the CRISPR patent conflict

Nature Biotechnology volume 33, pages 256–257 (2015)Cite this article

Subjects

Predicting the outcome of the ongoing patent disputes surrounding genome-editing technology is equal parts patent analysis and history.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jinek, M. et al. Science 337, 816–821 (2012).

    Article  CAS  Google Scholar 

  2. Jinek, M. et al. US Patent Application No. PCT/US2013/032589 (2013).

  3. Cong, L. et al. Science 339, 819–823 (2013).

    Article  CAS  Google Scholar 

  4. Zhang, F. US Patent No. 8,697,359 (2014).

  5. Miller, J.C., Rebar, E.J. & Zhang, S.H. US Patent Application No. 2014/0336133 (2014).

  6. 35 USC § 135 (2010).

  7. Madey v. Duke University, 357 F.3d 1351 (Fed. Cir. 2002).

  8. 35 USC § 271(e) (2012).

  9. 35 USC § 103 (2010).

  10. Feldman, M.P. et al. Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (eds. Krattiger, A. et al.) 1797–1807 (MIHR, Oxford, 2007).

    Google Scholar 

  11. Rojahn, S.Y. Broad Institute gets patent on revolutionary gene-editing method. MIT Technology Review http://www.technologyreview.com/view/526726/broad-institute-gets-patent-on-revolutionary-gene-editing-method/ (2014).

    Google Scholar 

  12. Fore, J. Jr., Wiechers, I.R. & Cook-Deegan, R. J. Biomed. Discov. Collab. 1, 7 (2006).

    Article  Google Scholar 

Download references

Acknowledgements

The author would like to thank Christopher Weyant for invaluable contributions to this paper.

Author information

Authors and Affiliations

  1. Jacob S. Sherkow is at the Institute for Information Law and Policy, New York Law School, New York, New York, USA.,

    Jacob S Sherkow

Authors
  1. Jacob S Sherkow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob S Sherkow.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sherkow, J. Law, history and lessons in the CRISPR patent conflict. Nat Biotechnol 33, 256–257 (2015). https://doi.org/10.1038/nbt.3160

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3160

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing